期刊文献+

炎症性肠病的抗生素治疗 被引量:4

Antibiotics in Inflammatory Bowel Disease
下载PDF
导出
摘要 炎症性肠病(IBD)主要包括克罗恩病(CD)和溃疡性结肠炎(UC),近年越来越多的证据提示肠道细菌在其发病中发挥重要作用。虽然目前尚未发现特异性细菌与IBD的发病相关,但随着现代微生物学的发展以及肠道细菌与IBD研究的进展,发现肠道细菌可能是参与IBD始动和持续的因素。因此,采用抗生素治疗IBD可能是一种有效的治疗措施。本文就抗生素对活动期CD、CD肛周病变、CD术后复发以及活动期UC和囊袋炎的疗效作一综述。 Inflammatory bowel disease (IBD) includes Crohn's disease (CD) and ulcerative colitis (UC), more and more evidences indicate that intestinal flora may play a pathogenic role in IBD in recent years. Although recent studies have not yet shown any specific pathogenic microorganism, however, with the development of microbiology and advances in intestinal flora and IBD, intestinal flora might be the initiating and perpetuating factor of IBD. Therefore, antibiotic treatment may be served as an efficient therapy for IBD. This article reviewed the efficacy of antibiotics in the treatment of active CD, perianal fistulas of CD, postoperative recurrence of CD, as well as in the treatment of active UC and pouehitis.
作者 张凤 冉志华
出处 《胃肠病学》 2010年第9期568-570,共3页 Chinese Journal of Gastroenterology
关键词 炎症性肠病 抗菌药 甲硝唑 环丙沙星 治疗 Inflammatory Bowel Disease Anti-Bacterial Agents Metronidazole Ciprofloxacin Therapy
  • 相关文献

参考文献25

  • 1张静,韩英,王继恒.炎症性肠病与肠道细菌研究进展[J].世界华人消化杂志,2007,15(12):1406-1410. 被引量:29
  • 2Maefarlane S,Steed H,Macfarlane GT.Intestinal bacteria and inflammatory bowel disease.Grit Rev Clin Lab Sci,2009,46(1):25-54.
  • 3白爱平.炎症性肠病发病机制的微生物因素[J].世界华人消化杂志,2006,14(7):645-649. 被引量:28
  • 4Duchmann R.The role of probiotics and antibiotics in regulating mucosal inflammation.Adv Exp Med Biol,2006,579:219-226.
  • 5Rath HC,Ikeda JS,Linde HJ,et al.Varying cecal bacterial loads influences colitis and gastritis in HLAB27 transgenic rats.Gastroenterology,1999,116(2):310-319.
  • 6Tannock GW.Molecular analysis of the intestinal microflora in IBD.Mucosal Immunol,2008,1 Suppl 1:S15-S18.
  • 7Koo HL,DuPont HL.Rifaximin:a unique gastrointestinal-selective antibiotic for enteric diseases.Curr Opin Gastroenterol,2010,26(1):17-25.
  • 8Shafran I,Burgunder P.Adjunctive antibiotic therapy with rifaximin may help reduce Crohn's disease activity.Dig Dis Sci,2010,55(4):1079-1084.
  • 9Doman DB,Goldberg HJ,Golding MI."Ecologic niche"therapy for Crohn's disease with adjunctive rifaximin antibiotic treatment followed by Flora-Q probiotic maintenance therapy.Am J Gastroenterol,2008,103(1):251-252.
  • 10Feller M,Huwiler K,Schoepfer A,et al.Long-term antibiotic treatment for Crohn's disease:systematic review and meta-analysis of placebo-controlled trials.Clin Infect Dis,2010,50(4):473-480.

二级参考文献56

  • 1白爱平.炎症性肠病发病机制的微生物因素[J].世界华人消化杂志,2006,14(7):645-649. 被引量:28
  • 2Chiodini RJ, Van Kruiningen HJ, Thayer WR, Coutu JA. Spheroplastic phase of mycobacteria isolated from patients with Crohn's disease. J Clin Microbiol 1986; 24: 357-363.
  • 3Sanderson JD, Moss MT, Tizard ML, Hermon-Taylor J. Mycobacterium paratuberculosis DNA in Crohn's disease tissue. Gut 1992; 33: 890-896.
  • 4Kreuzpaintner G, Das PK, Stronkhorst A, Slob AW, Strohmeyer G. Effect of intestinal resection on serum antibodies to the mycobacterial 45/48 kilodalton doublet antigen in Crohn's disease. Gut 1995; 37: 361-366.
  • 5Collins MT, Lisby G, Moser C, Chicks D, Chr-istensen S, Reichelderfer M, Hoiby N, Harms BA, Thomsen OO, Skibsted U, Binder V. Results of multple diagnostic tests for Mycobacterium avium subsp. paratuberculosis in patients with inflammat-ory bowel disease and in controls. J Clin Microbiol 2000; 38: 4373-4381.
  • 6Naser SA, Schwartz D, Shafran I. Isolation of Mycobacterium avium subsp paratuberculosis from breast milk of Crohn's disease patients. Am J Gastro-enterol 2000; 95: 1094-1095.
  • 7Wakefield AJ, Pittilo RM, Sim R, Cosby SL, Stephenson JR, Dhillon AP, Pounder RE. Evidence of persistent measles virus infection in Crohn's disease. J Med Virol 1993; 39: 345-353.
  • 8Robertson DJ, Sandler RS. Measles virus and Crohn's disease: a critical appraisal of the current literature. Inflamm Bowel Dis 2001; 7: 51-57.
  • 9Liu Y, van Kruiningen HJ, West AB, Cartun RW, Cortot A, Colombel JF. Immunocytochemical evide-nce of Listeria, Escherichia coli, and Streptoc-occus antigens in Crohn's disease. Gastroenterology 1995; 108: 1396-1404.
  • 10Cottone M, Pietrosi G, Martorana G, Casa A, Pec-oraro G, Oliva L, Orlando A, Rosselli M, Rizzo A, Pagliaro L. Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol 2001; 96: 773-775.

共引文献47

同被引文献33

  • 1邹宁,刘晓红,周旭东.克罗恩病与肠结核的临床分析与比较[J].临床内科杂志,2005,22(12):827-830. 被引量:26
  • 2吴晰,陆星华.我国克罗恩病患者临床表现分型的初步探讨[J].中华内科杂志,2006,45(8):661-663. 被引量:7
  • 3Stange E F, Travis S P L, Vermeire S, et al. European evidence based consensous on the diagnosis and management of Crohns disease:definitions and diagnosis[ J ]. Gut ,2006,55 ( Suppl 1 ) : il -i15.
  • 4Kornbluth A,Sachar D B. Ulcerative colitis practice guidelines in adults ( update ) : American College of Gastroenterology, Practice Parameters Committee [ J ]. Am J Gastroenterol,2004,99 ( 7 ) : 1371.
  • 5Hanauer S B. Review article:evolving concepts in treatment and disease modification in ulcerative colitis [ J ]. Aliment Pharmacol Ther, 2008,27 ( Suppl 1 ) : 15-21.
  • 6D' Haens G, Baert F, van Assche G, et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease : an open randomised trial [ J ]. Lancet, 2008, 371 (9613) :660-667.
  • 7Yamamoto T, Nakahigashi M, Umegae S, et al. Enteral nutrition for the maintenance of remission in Crohn ~ disease : a systematic review [ J ]. Eur J Gastroenterol Hepatol,2010,22 ( 1 ) : 1-8.
  • 8Zachos M,Tondeur M, Griffiths A M. Enteral nutritional therapy for induction of remission in Crohn ~s disease [ J ]. Cochrane Database Syst Rev ,2007,24 ( 1 ) : CD000542.
  • 9Akobeng A K. Review article:the evidence base for interventions used to maintain remission in Crohng disease [ J ]. Aliment Pharmacol Ther,2008,27( 1 ) :11-18.
  • 10Brittan M ,Alison M R,Schier S,Wright N A. Bone marrow stem cellmediated regeneration in IBD:where do we go from here? [ J ]. Gastxoentexology ,2007,132 ( 3 ) : 1171-1173.

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部